Diffuse Gastric Cancer: A Key Tumor Suppressor Is Set Off the Nuclear Stage

A new molecular alteration, consisting in the subcellular delocalization of the well known tumor suppressor protein pRb2/p130, has been recently identified, adding up a new component in the complex molecular portrait that characterizes gastric cancer.

The study, published in the Journal of Cellular Physiology, was led by the research team of Antonio Giordano, an internationally renowned pathologist, Director and Founder of the Sbarro Health Research Organization in Philadelphia, PA, and Professor of Pathology and Oncology at the University of Siena, Italy.

For more information, see the NewsWise press release

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s